Coronavirus Update: Inovio Begins Phase I Trials of DNA Vaccine, Fast-Track Drug Dialogue Continues
Plus: European Liver Meeting Postponed, AACR Goes Virtual
Executive Summary
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
You may also be interested in...
Inovio COVID-19 Vaccine Trial Delayed By FDA Partial Hold
The US FDA appears to have concerns about the device used to administer the vaccine.
Coronavirus Update: COVID-19 Funding Crisis For UK Medical Charities, Inovio Gets US Government Cash
UK medical research charities call for government assistance to temper damage caused by the pandemic, Inovio gets $71m in DOD contract to fund its vaccine, while ViralClear partners with Catalent to produce oral formulations of its antiviral merimepodib.
Coronavirus Sponsors Should Get Responses To Regulatory Requests Within One Day, US FDA Says
As part of the new Coronavirus Treatment Acceleration Program, FDA staff also are being reassigned to handle investigational therapy requests faster.